Pharmacogenomics Study on Treatment of Psoriasis Vulgaris by Methotrexate

NCT02715947 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis Vulgaris

Interventions

DRUG: Methotrexate

Sponsor

Central South University